Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Biocon Limited
BIOCON | BSE
238.45
INR2.00
0.85%
BIOCON | BSE
About Biocon Limited
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/09/2023
As of date
30/11/2023
Close
238.45
Open
238.45
High
239.10
Low
236.10
Biocon Limited a biopharmaceutical company manufactures pharmaceuticals and medicinal chemical and botanical products. The company operates through Generics Novel Biologics Biosimilars and Research Services segments. It focuses in the areas of diabetes oncology immunology ophthalmology and bone health diseases. In addition It is involved in the integrated discovery development and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru India.
View LessBIOCON | BSE
Risk
11.9%
Sharpe
-0.74
Luna's Score
54/100
Recommendation
Hold
Luna says (BIOCON | BSE)
What's Working
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
What's not Working
Midcap (2B - 10B USD)
Weak P/E, and PEG ratio indicator
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
13.1%1 month
11.9%3 months
24.0%6 months
28.0%Return
Fundamental Ratios
PE
56.44
Fwd. PE
0
Price to book
3.40
Debt to equity
0.96
Debt to assets
0.33
Ent. to EBITDA
17.23
Ent. to rev.
3.84
PEG
0
Other Fundamentals
EBITDA
32.43B
MarketCap
286.47B
MarketCap(USD)
3.44B
Div. yield
0.64
Op. margin
10.18
Erngs. growth
169.20
Rev. growth
49.30
Ret. on equity
4.07
Short ratio
0
Short perc.
0
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
10.75
Range1M
21.60
Range3M
62.45
Volumes: Market Activity
Rel. volume
0.63
Price X volume
23.72M
